Skip to main content

Table 1 Baseline characteristics of employees participating in a smoking cessation program

From: Predictors of marked weight gain in a population of health care and industrial workers following smoking cessation

Characteristics

All subjects (n = 654)

Long-term quitters (n = 229)

 

Demographics

 

Subjects without increase of body weight >5 % (n = 115)

Subjects with Increase of body weight >5 % (n = 114)

p-value

Age, years a

42.4 (±9.7)

43.4 (±9.7)

44.2 (±9.31)

0.53

Gender b

   

0.64

Male

369 (56)

61 (53)

65 (57)

 

female

285(44)

54 (47)

49(43)

 

Height, cm c

173 (167–180)

173 (168–180)

173 (167–180)

0.76

Weight, kg c

75.6 (64–84)

74.8 (64–83)

74.6 (65–84)

0.45

BMI a

25.1(±4.00)

25.1 (±4.23)

25.4 (±4.44)

0.52

Civil status b

   

0.47

single

218 (33)

36 (31)

35 (31)

 

married

330 (51)

57 (50)

61 (53)

 

divorced

95 (14)

19 (16)

18(16)

 

widowed

11 (2)

3 (3)

0 (0)

 

Education b

   

0.56

University

141 (22)

35 (31)

28 (25)

 

Apprenticeship

466 (72)

73 (64)

77 (68)

 

Basic education

41 (6)

6 (5)

8 (7)

 

Comorbidities b

    

Arterial hypertension

37 (6)

9 (8)

13 (7)

1.00

Coronary heart disease

28 (4)

11 (10)

2 (2)

0.02

Diabetes mellitus

16 (2)

12 (11)

13 (11)

1.00

Malignancy

27 (4)

5 (4)

4 (4)

1.00

Epilepsy

15 (2)

5 (4)

2 (2)

0.45

Psychiatric disorder

91 (14)

24 (21)

13 (11)

0.08

Antidepressant medication

112 (17)

23 (20)

16 (14)

0.31

Satisfaction with Life Scale (Qol), points c

26 (24–30)

27 (25–31)

26 (23–30)

0.82

Respiratory symptoms b

    

Cough

253 (39)

34 (30)

38 (34)

0.61

Sputum

176 (27)

25 (22)

26 (23)

0.97

Wheezing

124 (19)

26 (23)

17 (15)

0.19

Breathlessness at rest

44 (7)

12 (10)

10 (9)

0.84

Breathlessness on exertion

288 (44)

47 (41)

45 (39)

0.94

Smoking-related history

    

Age at starting smoking, years a

17 (±3.7)

17 (±3.8)

17 (±3.5)

1.00

Prior attempts to quit a

3.0 (±3.5)

2.9 (±3.3)

3.1 (±3.8)

0.78

Duration longest nicotine abstinence, months a

20 (±51)

21 (±45)

20 (±54)

0.69

Years, smoked a

22 (±8.5)

21 (±10.3)

22 (±8.5)

0.85

Number of cigarettes/day b

   

0.29

0-10

82 (13)

22 (19)

12 (11)

 

11-20

329 (50)

59 (51)

67 (59)

 

21-30

184 (28)

28 (24)

27 (24)

 

>30

58 (9)

6 (5)

8 (7)

 

FTND, points a

4.5 (±2.40)

3.7 (±2.40)

4.5 (±2.30)

0.02

Intensity of craving, (VAS 0–100) a

57 (±32)

58 (±32)

55 (±21)

0.09

Exhaled CO, ppm a

22.6 (±14.7)

20.2 (±15.1)

22.0 (±13.9)

0.38

Pharmacological support

   

0.91

NRT

    

Mono

82 (13)

12 (10)

11 (10)

 

Combined

124 (19)

24 (22)

21 (19)

 

Mono + Bupropion

92 (14)

12 (10)

13 (12)

 

Combined + Bupropion

265 (42)

52 (45)

57 (50)

 

Bupropion

42 (6)

5 (4)

5 (4)

 

Counselling only

47 (6)

10 (9)

6 (5)

 
  1. Data are illustrated for all subjects and permanent abstainers with and without significant change in body weight gain (def. Increase of body weight > 5 % as compared to baseline within 2-years)
  2. a Values are means ± SD, b absolute numbers (%) or c medians with interquartile ranges, BMI = Body mass index; FTND = Fagerstroem test for nicotine dependence, exhaled CO = exhaled carbon monoxide; NRT = Nicotine replacement therapy